ConductScience.org, home

Trial · NCT02143167

Resistance Training and Amino Pyridine in Multiple Sclerosis

NCT02143167, Phase 4, Completed, University of Southern Denmark

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Resistance Training and Amino Pyridine in Multiple Sclerosis. Trials, record NCT02143167. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02143167

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Resistance Training and Amino Pyridine in Multiple Sclerosis
NCT number
NCT02143167
Status
Completed
Phases
Phase 4
Enrollment
40 participants, actual
Lead sponsor
University of Southern Denmark
Conditions
Multiple Sclerosis
Interventions
SR-fampridine, Placebo
First posted
2014-05-20
Last updated
2018-08-23
Other registries' IDs
eudract:2011-002959-34

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryMuscle power in the lower limbsMuscle power will be measured after 14 weeks of resistance training.Muscle power in the lower limbs is measured by dynamometry pre and post resistance training
SecondaryActivityAccelerometry is measured after 14 weeks of resistance trainingActivity measured by accelerometry.
SecondaryWalking capacityWalking capacity is measured after 26 weeks of resistance trainingWalking capacity measured by the Six Spot Step Test (SSST)
SecondaryWalking speedWalking speed is measured after 26 weeks of resistance trainingWalking speed measured by the Timed 25 Foot Walk (T25FW) and the 6-Minute Walking Test (6MWT)
SecondaryFunctional capacity in the lower limbsFuncyional capacity in the lower limbs is measured after 26 weeks of resistance trainingFunctional capacity measured by the Chair Stand Test (CST)
SecondarySelf rated walking capacitySelf rated walking capacity is measured after 26 weeks of resistance trainingSelf rated walking capacity measured by the 12-Item Multiple Sclerosis Walking Scale (MSWS12)

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
19249634BACKGROUNDPubMed
19884575BACKGROUNDPubMed
20976768BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02143167

GET https://conductscience.org/api/trials/v1/NCT02143167/registered